AlphaVest Acquisition Corp filed a Proxy Supplement clarifying shareholder procedures for an upcoming Extension Meeting.
Quiver AI Summary
AlphaVest Acquisition Corp announced the filing of a Proxy Supplement related to its upcoming Extraordinary General Meeting on September 19, 2025, where shareholders will vote on a proposal to extend the time to complete a business combination with AV Merger Sub Inc and AMC Corporation. The Proxy Supplement clarifies the procedures for shareholders wishing to redeem their shares in connection with both the Extension Meeting and the prior Business Combination Meeting held on September 5, 2025. Shareholders must direct their banks or brokers to instruct the transfer agent for share redemptions by the deadline for the Extension Meeting. The Company plans to complete the Business Combination by September 22, 2025, if conditions are met, possibly canceling the Extension Meeting. However, if the Extension Meeting does not take place, shares submitted solely for that meeting will not be redeemed, while those submitted earlier will be processed.
Potential Positives
- Clarification of redemption procedures for shareholders enhances transparency and aids in shareholder decision-making regarding the business combination.
- The potential to cancel the Extension Meeting if the Business Combination is completed before the Termination Date demonstrates progress towards finalizing the merger.
- Indication that the company intends to complete the Business Combination by the Termination Date reflects a proactive approach to aligning timeline expectations for stakeholders.
- The filing of the Proxy Supplement signifies the company's commitment to maintaining communication and engagement with shareholders regarding significant decisions.
Potential Negatives
- The press release indicates uncertainty regarding the completion of the Business Combination, stating there is "no assurance" that the Extension Meeting will be held or the Extension implemented, which may create concern among investors.
- The necessity for shareholders to manage their redemption requests carefully adds complexity and potential confusion, which could lead to dissatisfaction or mistrust among shareholders.
- The ambiguity surrounding the timelines and conditions for the Business Combination could negatively impact investor confidence, as it raises concerns about the company's ability to meet its goals.
FAQ
What is the purpose of the AlphaVest Acquisition Corp Proxy Supplement?
The Proxy Supplement clarifies procedures for shareholders wishing to redeem their shares related to the Extension Meeting.
When is the Extension Meeting scheduled?
The Extension Meeting is scheduled for September 19, 2025.
What happens if the Extension Meeting is not held?
If not held, shares submitted for redemption in connection with the Business Combination Meeting will be automatically redeemed upon its consummation.
How can shareholders ensure their shares are redeemed?
Shareholders must instruct the transfer agent to redeem their public shares by the redemption deadline for the Extension Meeting.
What is AlphaVest Acquisition Corp’s business focus?
AlphaVest Acquisition Corp is a blank check company aiming to execute business combinations such as mergers and acquisitions.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ATMV Hedge Fund Activity
We have seen 5 institutional investors add shares of $ATMV stock to their portfolio, and 7 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- METEORA CAPITAL, LLC removed 294,436 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,468,456
- CENTIVA CAPITAL, LP removed 150,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $1,738,500
- TORONTO DOMINION BANK added 99,989 shares (+389.2%) to their portfolio in Q2 2025, for an estimated $1,177,870
- MIZUHO SECURITIES USA LLC added 89,221 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,051,023
- QUARRY LP added 65,600 shares (+133.7%) to their portfolio in Q2 2025, for an estimated $772,768
- BERKLEY W R CORP added 44,730 shares (+23.7%) to their portfolio in Q2 2025, for an estimated $526,919
- CLEAR STREET LLC added 10,620 shares (+96.1%) to their portfolio in Q2 2025, for an estimated $125,103
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
New York, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- AlphaVest Acquisition Corp (the “Company”) today filed a supplement (the “Proxy Supplement”) to its proxy statement dated September 2, 2025, related to its Extraordinary General Meeting to be held on September 19, 2025 (the “Extension Meeting”), at which shareholders will be able to consider and vote on a proposal to extend the time to complete the business combination (the “Extension”).
The Proxy Supplement clarified certain procedures related to shareholders wishing to redeem their ordinary shares in connection with the Extension Meeting and/or the Company’s business combination by and among the Company, AV Merger Sub Inc, and AMC Corporation (the “Business Combination”).
If you submitted public shares for redemption in connection with the extraordinary general meeting to approve the Business Combination, which was held on September 5, 2025 (the “Business Combination Meeting”) and you want to ensure such public shares are redeemed in the event that either the Business Combination is consummated or the Extension is implemented, you must (or must direct your bank, broker or other nominee to) instruct our transfer agent to redeem such public shares in connection with both the Business Combination Meeting and the Extension Meeting no later than the redemption deadline for the Extension Meeting. However, there is no assurance that we will hold the Extension Meeting and implement the Extension. If we do not hold the Extension Meeting implement the Extension, any public shares originally submitted for redemption in connection with the Business Combination Meeting and also instructed to be redeemed in connection with the Extension Meeting will be automatically subject to redemption in connection with the consummation of the Business Combination unless you withdraw such redemption request. However, if you only elect to redeem your public shares in connection with the Extension Meeting (and you did not previously submit such shares for redemption in connection with the Business Combination Meeting), your public shares will not be redeemed if we do not hold the Extension Meeting and implement the Extension, and you will receive shares of the combined public company.
If the conditions to the Business Combination are satisfied or will be satisfied or waived on or before September 22, 2025 (the “Termination Date”), then we intend to complete the Business Combination on or before the Termination Date. If we complete the Business Combination on or before the Termination Date, we expect to cancel the Extension Meeting. If we do not hold the Extension Meeting and implement the Extension, we will not redeem any public shares submitted for redemption solely in connection with the Extension Meeting (but will redeem all public shares previously submitted for redemption in connection with the Business Combination Meeting, and not subsequently reversed, upon consummation of the Business Combination). We intend to hold the Extension Meeting and implement the Extension only if we have determined as of the time of the extraordinary general meeting that we may not be able to complete the Business Combination on or before the Termination Date.
About AlphaVest Acquisition Corp
AlphaVest Acquisition Corp is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
For
investor and media inquiries, please contact:
David Yan
Email:
[email protected]
203-998-5540
Cautionary Note Regarding Forward Looking Statements
This press release may contain statements that constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the consummation of the Business Combination or implementation of the Extension. These forward-looking statements are based on the Company’s management’s current expectations, projections, and beliefs, as well as a number of assumptions concerning future events. When used in this communication, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose,” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside of management’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. These risks, uncertainties, assumptions, and other important factors include, but are not limited to risks and uncertainties indicated under “Risk Factors” contained in the definitive proxy statement/prospectus for the Business Combination, and other documents filed or to be filed with the Securities and Exchange Commission (the “SEC”) by the Company. Copies are available on the SEC’s website, www.sec.gov . You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made.
The Company assumes no obligation and, except as required by law, do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. The Company does not give any assurance that the Company will achieve its expectations.
No Offer or Solicitation
This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange any securities, or a solicitation of any vote or approval, nor shall there be any sale or exchange of securities in any jurisdiction in which such offer, solicitation, sale, or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended, or an exemption therefrom.